MedPath

Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation

Not Applicable
Completed
Conditions
Liver Transplantation
Liver Diseases
Mortality
Morbidity;Infant
Biliary Atresia
Interventions
Procedure: Liver Transplantation
Registration Number
NCT04778735
Lead Sponsor
Memorial Bahçelievler Hospital
Brief Summary

The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver transplantation. The aim of this study is to investigate the overall mortality, morbidity and risk factors for adverse outcomes in pediatric liver transplantation. The patients' records will be retrospectively scanned and the data will be gathered.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
207
Inclusion Criteria
  • Pediatric patients with liver transplantation (<18 years)
Exclusion Criteria
  • Patients with incomplete medical records will be excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pediatric Patients with Liver TransplantationLiver Transplantation-
Primary Outcome Measures
NameTimeMethod
Survival1 minutes

Patient and graft survival ratios

Secondary Outcome Measures
NameTimeMethod
Perioperative informations5 minutes

Perioperative informations such as blood loss and blood transfusion

Postoperative Complications5 minutes

Postoperative Complications such as sepsis or hepatic artery thrombosis

Postoperative informations10 minutes

Postoperative informations such as initial hospital stay, ICU stay or mechanic ventilation time

Blood Tests15 minutes

Blood markers that evaluated at the pre and post operative phase such as Internation Normalized Ratio (INR), total bilirubin and albumin values.

Trial Locations

Locations (1)

Memorial Bahçelievler Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath